>
pdufa.bio

LX1001

Updated ยทnext FDA decision on the calendar

LX1001 is a Lexeo Therapeutics, Inc. program. Its next catalyst is a Readout in Dec 2026. Every date links its source.

LXEO catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Lexeo Therapeutics, Inc. (LXEO). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Dec 2026LXEO

Questions

When is LX1001's next FDA decision or readout?

The next tracked catalyst for LX1001 is a Readout in Dec 2026.

What happened at LX1001's most recent FDA decision?

No FDA decision for LX1001 is in our archive yet.

Who makes LX1001?

Lexeo Therapeutics, Inc. (LXEO).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.